Variability of antibiotic prescribing for respiratory tract infections in two European countries;Variabilidad de la prescripción antibiótica en las infecciones respiratorias en dos países de Europa

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 23, Issue 10, 2005, Pages 598-604

  Llor, Carles ^a,d   Cots, Josep Maria ^a   Boada, Albert ^a   Bjerrum, Lars ^a   Gahrn Hansen, Bente ^b   Munck, Anders ^a   Forés, Dolors ^a   Miravitlles, Marc ^c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^d NONE   (Spain)

Author keywords

Antibiotics; Primary care; Respiratory tract infections

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; MACROLIDE; PENICILLIN G; PENICILLIN V;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DENMARK; DRUG USE; EAR INFECTION; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PARANASAL SINUS DISEASE; PRESCRIPTION; PRIMARY HEALTH CARE; REGISTER; RESPIRATORY TRACT INFECTION; SPAIN; TONSILLITIS;

EID: 29444445479     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13081568     Document Type: Article

References (30)

1. Picazo JJ, Pérez-Cecilia E, Herreras A, grupo DIRA en atención primaria. Estudio de las infecciones respiratorias extrahospitalarias. Estudio DIRA. Enferm Infecc Microbiol Clin. 2003;21:410-6.
2. Romero J, Rubio M, Corral O, Pacheco S, Agudo E, Picazo JJ. Estudio de las infecciones respiratorias extrahospitalarias. Enferm Infecc Microbiol Clin. 1997;15:289-98.
3. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet. 2001;357:1851-3.
4. Report of the ASM task force on antibiotic resistance. Antimicrob Agents Chemother. 1995;39 Suppl:1-23.
5. Magee JT, Pritchard EL, Fitzgerald KA, Dunatan FD, Howard AJ. Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-8. BMJ. 1999;319:1239-40.
6. Bronzwaer SL, Cars O, Buchholz U, Mölstad S, Goettsch W, Veldhuijzen IK, et al, European Antimicrobial Resistance Surveillance System. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8:278-82.
7. García-Rey C, Aguilar L, Baquero F, Casal J, Dal-Re R. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol. 2002;40:159-64.
8. Debbia EA, Shito GC, Pesce A, Marchese A. Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. Infection. 1999;27 Suppl 2:9-12.
9. Pradier C, Dunais B, Carsenti-Etesse H, Dellamonica P. Pneumococcal resistance patterns in Europe. Eur J Clin Microbiol Infect Dis. 1997;16:644-7.
10. Mölstad S, Lundborg CS, Karlsson AK, Cars O. Antibiotic prescription rates vary markedly between 13 European countries. Scand J Infect Dis. 2002;34:366-71.
11. Bjerrum L, Boada A, Cots JM, Llor C, Forés D, Gahrn-Hansen B, et al. Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain. Eur J Clin Pharmacol. 2004;60:23-8.
12. Munck A, Damsgaard J, Hansen DG, Bjerrum L, Søndergaard J. The Nordic method for quality improvement in general practice. Qual Prim Care. 2003;11:73-8.
13. Munck AP, Hansen DG, Lindman A, Ovhed I, Forre S, Torsteinsson JB. A Nordic collaboration on medical audit. The APO method for quality development and continuous medical education (CME) in primary health care. Scand J Prim Health Care. 1998;16:2-6.
14. Rønning M, Sakshaug S, editors. Guidelines for ATC classification. Oslo: World Health Organization; 1993.
15. Huchon GJ, Gialdroni-Grassi G, Leophonte P, Manresa F, Schaberg T, Woodhead M. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. Eur Respir J. 1996;9:1590-5.
16. Llor C, Reig R, Hernández S. Papel del factor demanda en la prescripción de antibióticos. Enferm Infec Microbiol Clin. 2003;21:61-2.
17. Lervy B, Wareham K, Cheung WY. Practice characteristics associated with audit activity: a medical audit advisory group survey. Br J Gen Pract. 1994;44:311-4.
18. Baker R, Robertson N, Farooqi A. Audit in general practice: factors influencing participation. BMJ. 1995;311:31-4.
19. Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy in general practice: differences between practitioners. Br J Gen Pract. 1999;49:195-8.
20. Munck A. Audit Project Odense (APO)-a Scandinavian Audit Centre for General Practice. Audit Trends. 1995;3:18-21.
21. Bjerrum L, Gahrn-Hansen B, Munck AP. C-reactive protein measurement in general practice may lead to lower antibiotic prescribing for sinusitis. Br J Gen Pract. 2004;54:659-62.
22. Dahler-Eriksen BS, Lauritzen T, Lassen JF, Lund ED, Brandslund I. Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clin Chem. 1999;45:478-85.
23. Hoffmann S. Detection of group A streptococcal antigen from throat swabs with five diagnostic kits in general practice. Diagn Microbiol Infect Dis. 1990;13:209-15.
24. Goossens H, Ferech M, Vander Stichele R, Elseviers M, ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365:579-87.
25. Marchese A, Schito GC. Resistance patterns of lower respiratory tract pathogens in Europe. Int J Antimicrob Agents. 2000;16 Suppl 1:25-9.
26. Jacobs MR, Felmingham D, Appelbaum PC, Gruneberg RN, The Alexander Project Group. The Alexander Project 1998-2000: susceptibility of pathogens isolated form community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother. 2003;52:229-46.
27. a ed. Barcelona: Edidé; 2001. p. 9-29.
28. Munck A, Gahrne-Hansen B, editors. Respiratory tract infections. Audit project Odense. Odense (Dinamarca): Research Unit of General Practice; 1998.
29. Álvarez F, Bouza E, García-Rodríguez JA, Mensá J, Monsó E, Picazo J, et al. Segundo documento de consenso sobre uso de antimicrobianos en la exacerbation de la enfermedad pulmonar obstructiva crónica. Arch Bronconeumol. 2003;39:274-82.
30. Bradley CP. Uncomfortable prescribing decisions: a critical incident study. BMJ. 1992;304:294-6.